China's top court rebuffs 'one product, one market' approach in TCM dispute
China's Supreme People's Court has ruled that four traditional Chinese medicine products shouldn't each be treated as standalone relevant markets in an abuse-of-dominance dispute, saying courts should instead assess demand substitutability...To view the full article, register now.
Already a subscriber? Click here to view full article